Lucid Diagnostics (LUCD) Revenue & Revenue Breakdown
Lucid Diagnostics Revenue Highlights
Latest Revenue (Y)
$4.35B
Latest Revenue (Q)
$1.21B
Lucid Diagnostics Revenue by Period
Lucid Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $4.35B | 178895.06% |
| 2023-12-31 | $2.43M | 544.03% |
| 2022-12-31 | $377.00K | -24.60% |
| 2021-12-31 | $500.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Lucid Diagnostics generated $4.35B in revenue during NA 2024, up 178895.06% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Lucid Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $1.21B | 104027.26% |
| 2025-06-30 | $1.16M | 40.46% |
| 2025-03-31 | $828.00K | -30.83% |
| 2024-12-31 | $1.20M | 2.13% |
| 2024-09-30 | $1.17M | 20.08% |
| 2024-06-30 | $976.00K | -2.50% |
| 2024-03-31 | $1.00M | -3.75% |
| 2023-12-31 | $1.04M | 32.82% |
| 2023-09-30 | $783.00K | 392.45% |
| 2023-06-30 | $159.00K | -64.35% |
| 2023-03-31 | $446.00K | 298.21% |
| 2022-12-31 | $112.00K | 47.37% |
| 2022-09-30 | $76.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $189.00K | -37.00% |
| 2021-12-31 | $300.00K | 50.00% |
| 2021-09-30 | $200.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Lucid Diagnostics generated $1.21B in revenue during Q3 2025, up 104027.26% compared to the previous quarter, and up 124077.87% compared to the same period a year ago.
Lucid Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.35B | $1.21B |
| OWLT | Owlet | $78.10M | $26.06M |
| SCLX | Scilex | $56.59M | $10.56M |
| RCEL | AVITA Medical | $50.56M | $18.42M |
| APYX | Apyx Medical | $48.10M | $12.88M |
| RPID | Rapid Micro Biosystems | $28.05M | $7.84M |
| SEER | Seer | $14.17M | $4.12M |
| IRD | Opus Genetics | $10.99M | - |
| AVR | Anteris Technologies Global | $2.73M | $618.00K |
| STSS | Sharps | - | $83.62K |
| IXHL | Incannex Healthcare | - | - |